🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Ireland / NCT06200519
Active, not recruiting Observational

Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography

NCT06200519 · tracked via the Priya Life Science Ireland tracker
Sponsor
University College Cork
Phase
Observational
Started
2024-02-12
Last updated
2026-03-04

Condition(s) studied

Diastolic DysfunctionNeonatal EncephalopathySmall for Gestational Age at DeliveryTransient Tachypnea of the NewbornTrisomy 21Gestational Diabetes

Study summary

The goal of this single-centre longitudinal observational study is to create reference values for diastolic function parameters in neonates born at 35 weeks' gestation or above, and to assess the influence of pre-defined antenatal, intrapartum, maternal, and neonatal factors on cardiac function.

The main question it aims to answer are:

* What are the normal reference ranges for parameters of diastolic cardiac function in neonates?
* How are these influenced by maternal, intrapartum and neonatal factors?
* Do the diastolic changes noted during the first two days of life persist into infancy?

Participants will have four echocardiographic assessments in total:

* Two during the first 48 hours of life (prior to discharge home)
* Two during infancy (as an outpatient)

Eligibility

Sex
ALL
Min age
6 Hours
Max age
18 Hours
Healthy volunteers
Accepted
Inclusion Criteria: * Birth at 35 weeks gestation or above * Informed consent obtained Exclusion Criteria: * Any apparent congenital anomalies * Any known chromosomal abnormalities (except Trisomy 21) * Any known congenital structural heart disease (except patent ductus arteriosus, atrial septal defect, patent foramen ovale or ventricular septal defect)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cork University Maternity Hospital Cork Ireland

More University College Cork trials in Ireland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06200519 on ClinicalTrials.gov ↗ ← All trials in Ireland